Clinical Trials Directory

Trials / Completed

CompletedNCT00816231

Drug /Cue Interactions In Alcohol-Tobacco Comorbidity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
244 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine how people react to different combinations of alcohol and nicotine.

Detailed description

The present project will improve and expand upon previously published work in several ways. First, Study 1 will assess reactivity to alcohol and smoking cues in the same session. Second, both studies will include within-subjects design factors to manipulate alcohol and nicotine intake, as well as cue types. Third, craving indices will represent three important response domains: subjective, physiological, and behavioral (e.g., Niaura et al., 1991). Fourth, each study will evaluate a range of drinkers and smokers, which will provide maximal information concerning influences on alcohol and smoking cue reactivity across various subject populations. The proposed studies are not only important from a theory development perspective, but they will provide an excellent foundation for future laboratory-based and clinical research.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTobaccoFive research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving tobacco with brief summary at the end of the last session.
OTHERAlcoholic BeverageFive research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving and alcohol with brief summary at the end of the last session.
OTHERPlaceboFive research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving placebo with brief summary at the end of the last session.

Timeline

Start date
2006-05-08
Primary completion
2014-03-01
Completion
2019-06-20
First posted
2009-01-01
Last updated
2019-09-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00816231. Inclusion in this directory is not an endorsement.